About Us

Gus Noureddine, M.D.

image82

Board Certified Sleep Specialist

Meet Our Sleep Specialist

American Board of Internal Medicine Board Certified in Sleep Medicine, Pulmonary Disease & Critical Care Medicine


Gus Noureddine, M.D. graduated from the American University of Beirut in 1990. His Internship and Residency in Internal Medicine was performed at John Hopkins University. His Allergy and Immunology fellowship was performed at John Hopkins University. His internship and residency in Pulmonary Disease and Sleep Medicine was performed at Baylor College of Medicine. 


Dr. Gus Noureddine was elected the Chief of Pulmonary Medicine at The Houston Methodist Hospital in 2015 and was recognized as an Outstanding Clinical Faculty by Baylor College of Medicine in 2005.


Dr. Gus Noureddine has had his practice the in the heart of the Texas Medical Center in Houston, Texas since 1998.


Clinical Research

Dr. Noureddine’s clinical research on Nasal and Bronchial response to Nasal Antigen challenge, in patients with Asthma and Allergic Rhinits, was conducted at John Hopkins University and Baylor College of Medicine.


Articles Published

Dr. Noureddine has had several articles published including:


Nasal Noureddine, G, Thompson, M, Brennan, F, Proud, D, Kagey-Sobotka, A, Lichtenstein, L et al. Nasal antigen challenge in asthmatics: effects of cetirizine on nasal and pulmonary responses [abstract]. J Allergy Clin Immunol. 1994; 93: 177


Lung elastic recoil during breathing at increased lung volume  Joseph R. Rodarte, Ghassan Noureddine, Charles Miller, Vito Brusasco, Riccardo Pellegrino, (With the Technical Assistance of Todd M. Officer)  Journal of Applied Physiology  Published 1 October 1999  Vol. 87  no.  4, 1491-1495


Nedocromil Sodium Worsens Ozone-Induced Lung Function Changes in Healthy Non-Smoking Subjects H. Canan Hasanoglu1, MD, Ghassan Noureddine, MD, Adnan Hasanoglu3, MD, William L. Eschenbacher2, MD, FCCP Journal of Turgut Özal Medical Center 5(1):1998   34-39


A Method to Improve Safety in Performing Inhaled Antigen Provocation Using Skin Test Titration, in 1997.